Newest alternative to Botox and Dysport is here
The introduction of Botox by Allergan in the 1990’s proved to be a paradigm shift in cosmetic surgery as it was a safe and easy treatment that worked and had no previous type of treatment. Obviously Botox was the first and still the
most popular neurotoxin (now called neuromodulator) with millions of treatments all over the world. Like any industry, progress introduces competition and several years ago Medicis introduced their product Dysport which although not exactly the same drug as Botox, has the same results. Dysport has caught on and is a popular option for some patients that prefer it to Botox for various reasons, one of them being it is a little less expensive.
Xeomin is the third neuromodulator to be FDA approved in this country and will represent yet another option for patients seeking improvement of facial wrinkles. Xeomin has been used around the world for safe and effective treatment of facial wrinkles since 1995. Although all these products are technically known as botulinum toxin A, they all have slightly different chemical structures. Xeomin is the first neuromodulator that is processed in a manner to eliminate a part of the molecule known as the accessory protein coat. It is this protein that contributes to allergic reactions. Users of Xeomin can expect the same results as Botox or Dysport although the initial price will probably be less. Otherwise the products are administered the same and have the same results that last the same amount of time. The number of units injected with Xeomin is compatible with Botox injections.
